[General and advanced aspects of treatment of vulvovaginal mycosis].
In treating candida vulvovaginitis attention has to be paid to the infection itself as well as to the importance of favouring conditions. With acute or non-recurring candida vulvovaginitis topical antimycotics have proved to be successful. In case of unsuccessful therapy or recurrence or chronicity the application of an intermitting topical or oral therapy is advised for an extended period of time, during or before the general symptoms, mainly premenstrually, occur. Today, an alternative to local therapy the short term application of modern oral azoles, Ketoconazole, Itraconazole, Fluconazole is suggested since no side effects are to be expected for short-time treatment. Thus adhesion-inhibitors might become a new possibility in therapy.
Ginter
G
G
Universitätsklinik für Dermatologie und Venerologie, Graz.
Pupp
C
C
D000284:Administration, Oral; D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D005260:Female; D006801:Humans
D000935:Antifungal Agents
Allgemeine und avantgardistische Aspekte in der Therapie der Vulvovaginalmykose.